Intracellular Antiviral Activity of Low-Dose Ritonavir in Boosted Protease Inhibitor Regimens

Protease inhibitors are largely used for the treatment of HIV infection in combination with other antiretroviral drugs. Their improved pharmacokinetic profiles can be achieved through the concomitant administration of low doses of ritonavir (RTV), a protease inhibitor currently used as a booster, in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: De Nicolò, Amedeo, Simiele, Marco, Calcagno, Andrea, Mohamed Abdi, Adnan, Bonora, Stefano, Di Perri, Giovanni, D'Avolio, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2014
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068548/
https://ncbi.nlm.nih.gov/pubmed/24798279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00104-14
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky